Your browser doesn't support javascript.
loading
CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens.
Forlani, Greta; Michaux, Justine; Pak, HuiSong; Huber, Florian; Marie Joseph, Elodie Lauret; Ramia, Elise; Stevenson, Brian J; Linnebacher, Michael; Accolla, Roberto S; Bassani-Sternberg, Michal.
Afiliação
  • Forlani G; Laboratories of General Pathology and Immunology "Giovanna Tosi", Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy.
  • Michaux J; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Pak H; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Huber F; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Marie Joseph EL; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Ramia E; Laboratories of General Pathology and Immunology "Giovanna Tosi", Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy.
  • Stevenson BJ; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Linnebacher M; Department of General Surgery, Molecular Oncology and Immunotherapy, University Medical Center Rostock, Rostock, Germany.
  • Accolla RS; Laboratories of General Pathology and Immunology "Giovanna Tosi", Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy.
  • Bassani-Sternberg M; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: Michal.bassani@chuv.ch.
Mol Cell Proteomics ; 20: 100032, 2021.
Article em En | MEDLINE | ID: mdl-33592498
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Proteínas Nucleares / Antígenos de Histocompatibilidade Classe II / Transativadores / Glioblastoma / Antígenos de Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Proteínas Nucleares / Antígenos de Histocompatibilidade Classe II / Transativadores / Glioblastoma / Antígenos de Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article